Drug Trial Radar · NCT02147899
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
Last checked: Nov 20, 2026Latest source record: Nov 13, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
215
Actual
Start
May 2014
Primary completion
Oct 2014
Study completion Oct 2014
Sponsor
- Lead sponsor
- Symbiomix TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- May 28, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this research study is to test the safety and effectiveness of the oral investigational new drug, SYM-1219, for the treatment of bacterial vaginosis.
Conditions
- Bacterial Vaginosis
Interventions
SYM-1219Drug
Oral
PlaceboDrug
Oral
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cure of Bacterial VaginosisTime frame: Study Days 21-30
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Women's Health Care Research Corp.
San Diego, California
Women's Medical Research Group, LLC
Clearwater, Florida
Healthcare Clinical Data, Inc.
North Miami, Florida
Atlanta North Gynecology, P.C
Roswell, Georgia
Wayne State University
Detroit, Michigan
Saginaw Valley Medical Research Group, LLC
Saginaw, Michigan
Lawrence OB-GYN Clinical Research, LLC
Lawrenceville, New Jersey
Scott Eder MD
Plainsboro, New Jersey
Eastern Carolina Women's Center
New Bern, North Carolina
Clinical Research of Philadelphia, LLC
Philadelphia, Pennsylvania
The Jackson Clinic, PA
Jackson, Tennessee
TMC Life Research, Inc.
Houston, Texas
Clinical Trials of Texas, Inc.
San Antonio, Texas
Tidewater Physicians for Women
Virginia Beach, Virginia
University of Washington, Harborview Medical Center
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.